Cargando…
Biguanides suppress hepatic glucagon signaling by decreasing production of cyclic AMP
Autores principales: | Miller, Russell A., Chu, Qingwei, Xie, Jianxin, Foretz, Marc, Viollet, Benoit, Birnbaum, Morris J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573218/ https://www.ncbi.nlm.nih.gov/pubmed/23292513 http://dx.doi.org/10.1038/nature11808 |
Ejemplares similares
-
AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B
por: Johanns, M., et al.
Publicado: (2016) -
Activation of AMPK for a Break in Hepatic Lipid Accumulation and Circulating Cholesterol
por: Foretz, Marc, et al.
Publicado: (2018) -
Glucagon, cyclic AMP, and hepatic glucose mobilization: A half‐century of uncertainty
por: Rodgers, Robert L.
Publicado: (2022) -
AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development
por: Boudaba, Nadia, et al.
Publicado: (2018) -
AMPK Activation Reduces Hepatic Lipid Content by Increasing Fat Oxidation In Vivo
por: Foretz, Marc, et al.
Publicado: (2018)